Inbiomotion
4 known investors
Find your way into Inbiomotion
Sign up to see every warm intro you have to Inbiomotion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inbiomotion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients. The test helps oncologists reduce relapse risk and improve survival outcomes through precision medicine approaches.
Founders & leadership
Board
Investors · 4
How we know: Asabys Partners's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Ysios Capital's portfolio page · a partner's Signal profile · funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
Frequently asked questions
- What does Inbiomotion do?
- InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients. The test helps oncologists reduce relapse risk and improve survival outcomes through precision medicine approaches.
- Who are Inbiomotion's investors?
- Inbiomotion's investors include Asabys Partners, Criteria Bio Ventures, Ysios Capital, Alta Life Sciences.


